Search

The patents juggernaut chugs out of the lay-by as Charlie McCreevy sets out his latest vision following the large scale consultation that took place earlier this year.

On September 21, 2006, the Russian Parliament approved in the first reading a new draft law on intellectual property. Following the approval, First Deputy Prime Minister Dmitry Medvedev said the draft meets international requirements set for Russia and is aimed at Russia's accession to the WTO.

Finding the magic ingredients that will generate innovation remains a major preoccupation across the public and private sectors. Two leading protagonists from academe and industry shares their thoughts.

Microsoft France's support scheme for start-ups has begun its second year, with success at just one of the 25 companies it has helped covering the costs of the programme over two years. And now Microsoft’s subsidiaries in Germany and the UK are joining in.

The Hungarian biotech sector is ahead of the rest of the new European Union member states pack, but it remains stymied by a lack of managers with a scientific background.

The common wisdom among technology-policy analysts is that Europe is bad at transferring technology out of its great universities and into the commercial world. A new study asserts that, by some measures, Europe may actually outperform the U.S., Canada and Australia.

A new report in the USA will be the basis for some of the work on the health and safety of nanotechnology.

The latest announcement from BASF Venture Capital America Inc. brings back memories of the dash for energy R&D 30 years ago.

A battle between IBM and Microsoft for the hearts and minds of tech start-ups took a new turn as IBM announced free technical-development help to promising VC-backed firms.

Milken Institute, a California-based think-tank founded by famous financier Michael Milken, published earlier this week a report on global trends in university biotechnology transfer. This is an impressive piece of work, carried out by a research team of nine and drawing on every conceivable source of data.

A new study shows that universities in the USA still rule the roost when it comes to biotech research, not to mention turning it into cash.

US institutions are dominant in a survey of bio tech transfer published by the Miliken Foundation covering publications, patenting and tech transfer outcomes.

A transatlantic collaboration that will systematically uncover the function of human genes and make the findings public got under way earlier this month.

Just over half of Europe’s scientifically qualified work force is female, but fewer than one in three of Europe’s professional scientists and technologists are women...